WBA
Get informed when a big investor buys or sells
+ FollowUndervalued by 71.2% based on the discounted cash flow analysis.
| Market cap | $10.37 Billion |
|---|---|
| Enterprise Value | $38.87 Billion |
| Dividend Yield | $0.25 (2.09%) |
| Earnings per Share | $-10.01 |
| Beta | 0.77 |
| Outstanding Shares | 864,900,000 |
| P/E Ratio | -3.42 |
|---|---|
| PEG | 2.27 |
| Price to Sales | 0.07 |
| Price to Book Ratio | 1.5 |
| Enterprise Value to Revenue | 0.25 |
| Enterprise Value to EBIT | -9.6 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.75 |
| Debt to Equity | 4.07 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0851▲ 23.63% |
|---|---|
| Total Calls | 21,805,800▼ 16.46% |
| Total Puts | 23,662,223▲ 6.80% |
Holdings and activity of institutional investors.
| Ownership % | 62.99%▲ 1.46% |
|---|---|
| Total Invested | $6.25B▲ 3.79% |
| Investors Holding | 874▼ 43.00% |
No data
This committee directly impacts WBA through its control over taxation (corporate tax policy) and entitlement spending, particularly Medicare pricing, which is a critical factor for pharmacy reimbursement rates and profitability.
This committee directly allocates discretionary federal spending, which includes funding for government healthcare programs (e.g., Medicare, Medicaid, VA) whose reimbursement rates significantly impact WBA's pharmacy revenue.
This committee's regulation of the FDA (drug approval and safety) directly impacts products WBA sells, and its influence on labor laws (minimum wage, unionization) directly affects WBA's significant workforce and operating costs.
This committee directly investigates issues affecting older Americans, including drug pricing and long-term care quality, which are highly relevant to WBA's core pharmacy business and can generate significant headline risk and legislative pressure.
This committee's jurisdiction over interstate commerce and the FTC directly impacts WBA's retail and consumer protection practices, advertising, and data privacy regulations as a large national retailer.